Bioorganic and Medicinal Chemistry Letters p. 1047 - 1050 (1996)
Update date:2022-08-03
Topics:
Willson, Timothy M.
Henke, Brad R.
Momtahen, Tanya M.
Garrison, Deanna T.
Moore, Linda B.
Geddie, Nora G.
Baer, Philip G.
The utility of the bone targeting 4-carboxy-3-hydroxy-1,2-pyrazole heterocycle was tested by the synthesis of hybrids with the non-steroidal estrogen hexestrol. Compounds 1 and 2 demonstrated significant hydroxyapatite affinity, while maintaining weak estrogenic activity in whole cell assays. Copyright
View MoreXian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-88211911
Address:Keji Road NO.70
Guangzhou Congen Pharmatec Co.,Ltd.
website:https://www.congenpharma.com
Contact:86-020-82350801
Address:Room 501, Building G11, South China Advanced Materials Innovation Park, 31 Kefeng Road, Science City, Guangzhou, China 510663
WEIFANG RICHEM INTERNATIONAL LTD
Contact:86-536-2222176
Address:weifang,shandong
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge，Yueyang Economy & Technology Development Zone
TIANJIN FESTO CHEMICAL CO.,LTD(expird)
Contact:86-22-25814570
Address:No.12th,5th Ave.,TEDA,Tianjin,China
Doi:10.1016/0040-4039(96)00834-9
(1996)Doi:10.1021/jo800185v
(2008)Doi:10.1021/jo702377h
(2008)Doi:10.1016/S0040-4020(01)81352-1
(1994)Doi:10.1016/S0022-2860(00)00445-2
(2000)Doi:10.1002/chem.201203684
(2013)
